<DOC>
	<DOCNO>NCT01153347</DOCNO>
	<brief_summary>The purpose study determine TC-5214 placebo ( tablet look like medicine tablet capsule , contain active medicine ) safe effective take together another antidepressant .</brief_summary>
	<brief_title>A Study Assess Efficacy Safety TC-5214 Adjunct Therapy Patients With Major Depressive Disorder</brief_title>
	<detailed_description />
	<mesh_term>Disease</mesh_term>
	<mesh_term>Depression</mesh_term>
	<mesh_term>Depressive Disorder</mesh_term>
	<mesh_term>Depressive Disorder , Major</mesh_term>
	<mesh_term>Serotonin</mesh_term>
	<mesh_term>Serotonin Uptake Inhibitors</mesh_term>
	<criteria>Provision sign date informed consent initiation studyrelated procedure . The patient must clinical diagnosis major depressive disorder ( MDD ) inadequate response one antidepressant . Outpatient status enrollment randomization . Patients lifetime history bipolar disorder , psychotic disorder posttraumatic stress disorder . Patients history suicide attempt past year and/or see investigator significant history risk suicide homicide . History renal insufficiency impairment condition could affect absorption metabolism investigational product .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>March 2014</verification_date>
	<keyword>Major Depressive Disorder</keyword>
	<keyword>MDD</keyword>
	<keyword>Depression</keyword>
	<keyword>Safety</keyword>
	<keyword>add-on therapy</keyword>
</DOC>